Odanacatib (Standard)
Odanacatib (Standard) is the analytical standard of Odanacatib. This product is intended for research and analytical applications. Odanacatib (MK-0822) is a potent and selective inhibitor of cathepsin K, with an IC50 of 0.2 nM for human cathepsin K.
Product Specifications
CAS Number
603139-19-1
Target
Cathepsin; Reference Standards
Related Pathways
Metabolic Enzyme/Protease; Others
Field of Research
Metabolic Disease; Cancer
Smiles
N#CC1(NC([C@@H](N[C@H](C(F)(F)F)C2=CC=C(C3=CC=C(S(=O)(C)=O)C=C3)C=C2)CC(C)(F)C)=O)CC1
Molecular Formula
C25H27F4N3O3S
Molecular Weight
525.56
References & Citations
[1]Jacques Yves Gauthier, et al. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg Med Chem Lett. 2008 Feb 1;18 (3) :923-8.|[2]Leung P, et al. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. Bone. 2011 Oct;49 (4) :623-635.|[3]Ng KW. Potential role of odanacatib in the treatment of osteoporosis. Clin Interv Aging. 2012;7:235-47.|[4]Yi C, et al. Inhibition of cathepsin K promotes osseointegration of titanium implants in ovariectomised rats. Sci Rep. 2017 Mar 17;7:44682.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E3500-06J1 1 mL
Escherichia coli, O, K Serotypes, Glycerol Free (E. coli) discontinued. see E3500-06J
Sign In for Pricing
View Details 
30678121 3x 1.0µg DNA
MRX70 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details abx006208-01 20 µL
Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Antibody
Sign In for Pricing
View Details abx006208-02 100 µL
Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Antibody
Sign In for Pricing
View Details abx006208-03 2x 100 µL
Golgi-Specific Brefeldin A-Resistance Guanine Nucleotide Exchange Factor 1 (GBF1) Antibody
Sign In for Pricing
View Details